Faropenem Medoxomil

Preferred Label : Faropenem Medoxomil;

NCIt synonyms : Faropenem Daloxate; (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl-(5R,6S)-6-[(R)-1-hydroxyethyl]-7-oxo-3-[(R)-2-tetrahydrofuryl]-4-thia-1-aza-bicyclo[3,2,0]hept-2-ene-carboxylate;

NCIt definition : A daloxate ester prodrug form of faropenem, a penem with a tetrahydrofuran substituent at position C2, with broad-spectrum antibacterial activity against many gram-positive and gram-negative aerobes and anaerobes. Faropenem medoxomil is hydrolyzed in vivo to release the active free acid. Compared with imipenem, faropenem has improved chemical stability and reduced central nervous system effects. In addition, faropenem is resistant to hydrolysis by many beta-lactamases.;

UNII : 5OK523O4FU;

InChIKey : JQBKWZPHJOEQAO-DVPVEWDBSA-N;

CAS number : 141702-36-5;

Chemical formula : C17H19NO8S;

Details

Origin ID

C65621;

UMLS CUI

C1880735;

Currated CISMeF NLP mapping
- Faropenem medoxomil [SMS substance]
- faropenem medoxomil [MeSH concept]
- faropenem medoxomil [MeSH Supplementary Concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- faropenem medoxomil [MeSH concept]
- faropenem medoxomil [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients